{"name": "Limerick BioPharma",
 "permalink": "limerick-biopharma",
 "crunchbase_url": "http://www.crunchbase.com/company/limerick-biopharma",
 "homepage_url": "http://www.limerickbio.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2004,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "mailbox@limerickbio.com",
 "phone_number": "650-742-0110",
 "description": "Compound Developer",
 "created_at": "Sun Jun 14 22:47:50 UTC 2009",
 "updated_at": "Mon Dec 27 02:40:08 UTC 2010",
 "overview": "\u003Cp\u003ELimerick BioPharma is dedicated to developing compounds that, when used adjunctively with both marketed and investigational drugs, significantly improve the quality of patients\u00e2\u20ac\u2122 lives. Their compounds minimize toxic side effects at non-targeted vulnerable organs and tissue while maintaining or enhancing a drug\u00e2\u20ac\u2122s desired effects. In the monotherapy setting, they are developing novel compounds that target the treatment of metabolic diseases such as hypercholesteremia and hyperglycemia.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[125,
       102],
      "assets/images/resized/0004/8497/48497v1-max-150x150.png"],
     [[125,
       102],
      "assets/images/resized/0004/8497/48497v1-max-250x250.png"],
     [[125,
       102],
      "assets/images/resized/0004/8497/48497v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Asha",
      "last_name": "Rajagopal",
      "permalink": "asha-rajagopal",
      "image":
       {"available_sizes":
         [[[127,
            150],
           "assets/images/resized/0026/0299/260299v1-max-150x150.jpg"],
          [[150,
            176],
           "assets/images/resized/0026/0299/260299v1-max-250x250.jpg"],
          [[150,
            176],
           "assets/images/resized/0026/0299/260299v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$35.3M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://deals.venturebeat.com/?p=108376",
    "source_description": "Limerick BioPharma raises $1.5M to limit drug side effects",
    "raised_amount": 1500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 6,
    "funded_day": 13,
    "investments":
     []},
   {"round_code": "unattributed",
    "source_url": "http://deals.venturebeat.com/2008/06/11/limerick-biopharma-raises-152m-for-drug-bioavailability/",
    "source_description": "Limerick BioPharma raises $15.2M for drug bioavailability",
    "raised_amount": 15200000.0,
    "raised_currency_code": "USD",
    "funded_year": 2008,
    "funded_month": 6,
    "funded_day": 11,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "ARCH Venture Partners",
         "permalink": "arch-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               31],
              "assets/images/resized/0003/6165/36165v2-max-150x150.png"],
             [[250,
               51],
              "assets/images/resized/0003/6165/36165v2-max-250x250.png"],
             [[300,
               62],
              "assets/images/resized/0003/6165/36165v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Sevin Rosen Funds",
         "permalink": "sevin-rosen-funds",
         "image":
          {"available_sizes":
            [[[98,
               87],
              "assets/images/resized/0003/0241/30241v1-max-150x150.jpg"],
             [[98,
               87],
              "assets/images/resized/0003/0241/30241v1-max-250x250.jpg"],
             [[98,
               87],
              "assets/images/resized/0003/0241/30241v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Altitude Life Science Ventures",
         "permalink": "altitude-life-science-ventures",
         "image":
          {"available_sizes":
            [[[150,
               47],
              "assets/images/resized/0004/6467/46467v2-max-150x150.png"],
             [[250,
               79],
              "assets/images/resized/0004/6467/46467v2-max-250x250.png"],
             [[289,
               92],
              "assets/images/resized/0004/6467/46467v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "c",
    "source_url": "http://www.fiercebiotech.com/story/limerick-lands-15m-series-c/2009-07-15?utm_medium=rss\u0026utm_source=rss\u0026cmp-id=OTC-RSS-FB0",
    "source_description": "Limerick lands $15M in Series C",
    "raised_amount": 15000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 7,
    "funded_day": 15,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "ARCH Venture Partners",
         "permalink": "arch-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               31],
              "assets/images/resized/0003/6165/36165v2-max-150x150.png"],
             [[250,
               51],
              "assets/images/resized/0003/6165/36165v2-max-250x250.png"],
             [[300,
               62],
              "assets/images/resized/0003/6165/36165v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Sevin Rosen Funds",
         "permalink": "sevin-rosen-funds",
         "image":
          {"available_sizes":
            [[[98,
               87],
              "assets/images/resized/0003/0241/30241v1-max-150x150.jpg"],
             [[98,
               87],
              "assets/images/resized/0003/0241/30241v1-max-250x250.jpg"],
             [[98,
               87],
              "assets/images/resized/0003/0241/30241v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Altitude Life Science Ventures",
         "permalink": "altitude-life-science-ventures",
         "image":
          {"available_sizes":
            [[[150,
               47],
              "assets/images/resized/0004/6467/46467v2-max-150x150.png"],
             [[250,
               79],
              "assets/images/resized/0004/6467/46467v2-max-250x250.png"],
             [[289,
               92],
              "assets/images/resized/0004/6467/46467v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "debt_round",
    "source_url": "http://www.xconomy.com/san-francisco/2010/12/23/limerick-biopharma-lands-3585000-new-funding-round/",
    "source_description": "Limerick BioPharma Lands $3,585,000 New Funding Round",
    "raised_amount": 3585000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 12,
    "funded_day": 23,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "601 Gateway Blvd., Suite 700",
    "address2": "",
    "zip_code": "94080",
    "city": "South San Francisco",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 37.658713,
    "longitude": -122.399382}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        88],
       "assets/images/resized/0004/8496/48496v1-max-150x150.png"],
      [[250,
        147],
       "assets/images/resized/0004/8496/48496v1-max-250x250.png"],
      [[450,
        264],
       "assets/images/resized/0004/8496/48496v1-max-450x450.png"]],
    "attribution": null}],
 "external_links":
  []}